When the blood pressure drug Bystolic hit the market in 2008, it faced a crowded field of cheap generics. So its maker, Forest Laboratories, launched a promotional assault on the group in the best ...
"Bystolic is the newest beta blocker approved for the treatment of hypertension in the U.S. and should prove useful due to its efficacy in a broad range of patients and its favorable side effect ...
When the blood pressure drug Bystolic hit the market in 2008, it faced a crowded field of cheap generics. So its maker, Forest Laboratories, launched a promotional assault on the group in the best ...
NEW YORK (AP) -- Forest Laboratories Inc. said Thursday that it resolved another lawsuit with a company that wanted marketing approval for a generic version of its blood pressure drug Bystolic. The ...
NEW YORK (AP) -- Forest Laboratories Inc. said Thursday that Canadian regulators approved its high blood pressure drug Bystolic. Forest said Bystolic will be available in Canada starting in the second ...
Forest Labs may have settled a patent challenge from generics maker Hetero, but the drugmaker has yet to come to terms with six others seeking to market BP med Bystolic before its patent runs out.
MONTGOMERY, Ala.--(BUSINESS WIRE)--Kowa Pharmaceuticals America, Inc. announced today that it has entered into an agreement with Allergan plc. to co-promote Allergan’s BYSTOLIC ® (nebivolol), a beta ...
AbbVie and a slate of generic drugmakers won a reprieve against claims they conspired to stall generics of the blood pressure med Bystolic in the U.S. A federal judge in New York tentatively scrapped ...
BOSTON (Reuters) - Forest Laboratories Inc said on Thursday the U.S. Patent Office rejected all pending claims involving a patent covering the company's hypertension drug Bystolic, sending its shares ...
Q I take Bystolic for blood pressure and was instructed to take it in the morning. The side effects leave me feeling washed out, drowsy and listless all day. Since blood pressure is lower during sleep ...
NEW YORK A Forest Labs drug used to treat mild to moderate hypertension “significantly” reduced blood pressure in Hispanic patients when used alone, according to post-marketing study data presented ...
When the blood pressure drug Bystolic hit the market in 2008, it faced a crowded field of cheap generics. So its maker, Forest Laboratories, launched a promotional assault on the group in the best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback